Key facts
- Jade Biosciences stock is down 9% today.
- The reason for the stock slide is not provided.
Jade Biosciences stock experienced a 9% decline today. The specific catalyst for this downward movement was not detailed in the provided news content. This event follows the company's recent pricing of a $150 million public offering of common stock at $15 per share. The capital raised from that offering is intended for the company's general business objectives. The reason for the current stock slide remains undisclosed.